Skip to search formSkip to main contentSkip to account menu

Bondronat

Known as: Bondronate 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Ibandronateibandronic acid

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Hypercalcémie maligne révélant un adénome parathyroïdien chez une patiente en insuffisance rénale
2009
2009
Влияния ибандроната на метаболизм костной ткани у диализных пациентов с вторичным гиперпаратиреозом
The effect of Bondronat (ibandronic acid) on the mineral density of the bone tissue and blood levels of parathyroid hormone… 
2009
2009
Bondronat® in der klinischen Praxis: Anhaltende Reduktion der Knochenschmerzen bei Patienten mit ossär metastasiertem Mammakarzinom
2009
2009
Bondronat ® in der klinischen Praxis: Renale Verträglichkeit bei Patienten mit ossär metastasiertem Mammakarzinom
2005
2005
Bisphosphonates in metastatic bone disease: renal safety matters.
Correspondence: Jean-Jacques Body, M.D., Ph.D., Institut Jules Bordet, Universite Libre de Bruxelles, 1 Rue Heger-Bordet, 1000… 
2005
2005
Bisphosphonate treatment recommendations for oncologists.
: Renal safety is an important consideration for oncologists who are treating patients with bisphosphonates. In recent years… 
Review
2004
Review
2004
Safety and convenience of a 15-minute infusion of zoledronic acid.
Skeletal morbidity, including hypercalcemia of malignancy (HCM), places a severe burden on patients with advanced cancers… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)